Search research articles
Contact Us
Filters
Showing results (81-90 of 389) with videos related to
Page
of 39
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 20, 2017
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use
Cecilie Bhandari Hartberg, Elisabeth H Lange, Trine Vik Lagerberg, et al.
Bipolar Disorders
|
March 27, 2015
Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder
Cecilie Bhandari Hartberg, Kjetil Nordbø Jørgensen, Unn Kristin Haukvik, et al.
Lakartidningen
|
October 14, 2015
[New findings about schizophrenia can provide new diagnostics and treatment]
Martin Schalling, Göran Engberg, Ole Andreassen, et al.
Psychiatry Research
|
April 5, 2012
Is cognitive impairment following early life stress in severe mental disorders based on specific or general cognitive functioning?
Monica Aas, Nils E Steen, Ingrid Agartz, et al.
Schizophrenia Research
|
November 27, 2012
Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder
P Andreas Ringen, Ingrid Melle, Akiah O Berg, et al.
BMC Psychiatry
|
January 10, 2009
Apathy is associated with executive functioning in first episode psychosis
Ann Faerden, Anja Vaskinn, Arnstein Finset, et al.
Schizophrenia Bulletin
|
September 13, 2011
Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders
Monica Aas, Srdjan Djurovic, Lavinia Athanasiu, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 10, 2014
ANK3 gene expression in bipolar disorder and schizophrenia
Katrine Verena Wirgenes, Martin Tesli, Elin Inderhaug, et al.
BMC Psychiatry
|
January 29, 2010
Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study
Trine V Lagerberg, Ole A Andreassen, Petter A Ringen, et al.
Schizophrenia Research
|
July 24, 2012
Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein
Ingrid Dieset, Sigrun Hope, Thor Ueland, et al.
Page
of 39
Search research articles
Search
Showing results (81-90 of 389) with videos related to
Sort By:
Page
of 39
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 20, 2017
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use
Cecilie Bhandari Hartberg, Elisabeth H Lange, Trine Vik Lagerberg, et al.
Bipolar Disorders
|
March 27, 2015
Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder
Cecilie Bhandari Hartberg, Kjetil Nordbø Jørgensen, Unn Kristin Haukvik, et al.
Lakartidningen
|
October 14, 2015
[New findings about schizophrenia can provide new diagnostics and treatment]
Martin Schalling, Göran Engberg, Ole Andreassen, et al.
Psychiatry Research
|
April 5, 2012
Is cognitive impairment following early life stress in severe mental disorders based on specific or general cognitive functioning?
Monica Aas, Nils E Steen, Ingrid Agartz, et al.
Schizophrenia Research
|
November 27, 2012
Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder
P Andreas Ringen, Ingrid Melle, Akiah O Berg, et al.
BMC Psychiatry
|
January 10, 2009
Apathy is associated with executive functioning in first episode psychosis
Ann Faerden, Anja Vaskinn, Arnstein Finset, et al.
Schizophrenia Bulletin
|
September 13, 2011
Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders
Monica Aas, Srdjan Djurovic, Lavinia Athanasiu, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 10, 2014
ANK3 gene expression in bipolar disorder and schizophrenia
Katrine Verena Wirgenes, Martin Tesli, Elin Inderhaug, et al.
BMC Psychiatry
|
January 29, 2010
Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study
Trine V Lagerberg, Ole A Andreassen, Petter A Ringen, et al.
Schizophrenia Research
|
July 24, 2012
Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein
Ingrid Dieset, Sigrun Hope, Thor Ueland, et al.
Page
of 39